"Europe Next Generation Sequencing (NGS) Market Summary:

According to the latest report published by Data Bridge Market Research, the Europe Next Generation Sequencing (NGS) Market

CAGR Value 

The Europe Next Generation Sequencing (NGS) market size was valued at USD 4.87 billion in 2025 and is expected to reach USD 15.63 billion by 2033, at a CAGR of 15.7% during the forecast period

The large scale Europe Next Generation Sequencing (NGS) Market report is produced with the several decisive factors. These consist of primary research, benchmarking studies, secondary research, company profiles, competitive intelligence & reporting, syndicated research, data collection, data processing and analysis, survey design, and survey programming. The report also endows with evaluations based on the market type, organization size, availability on-premises, end-users’ organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. The persuasive Europe Next Generation Sequencing (NGS) Market business report considers new product development from beginning to launch by performing detailed market study.

Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/europe-next-generation-sequencing-ngs-market

Europe Next Generation Sequencing (NGS) Market Segmentation and Market Companies

Segments

- By Product & Service
- Reagents, Consumables, & Accessories
- Sequencing Services
- Platforms
- By Technology
- Sequencing By Synthesis (SBS)
- Ion Semiconductor Sequencing
- Sequencing By Ligation (SBL)
- Pyrosequencing
- Single-Molecule Real-Time (SMRT) Sequencing
- Other Technologies
- By Application
- Diagnostic
- Drug Discovery
- Biomarker Discovery
- Precision Medicine
- Agriculture & Animal Research
- Others
- By End User
- Academic Institutes & Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other End Users

The European Next Generation Sequencing (NGS) market is segmented based on various factors that impact the industry. By product & service, the market is bifurcated into reagents, consumables, & accessories, sequencing services, and platforms. Moving on to the technology segment, the market is divided among sequencing by synthesis (SBS), ion semiconductor sequencing, sequencing by ligation (SBL), pyrosequencing, single-molecule real-time (SMRT) sequencing, and other technologies. In terms of application, the NGS market is categorized into diagnostic, drug discovery, biomarker discovery, precision medicine, agriculture & animal research, and others. Lastly, based on end users, the market serves academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users.

Market Players

- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California, Inc.
- BGI Group
- PerkinElmer Inc.
- Agilent Technologies, Inc.
- Qiagen
- Eurofins Scientific
- Macrogen, Inc.

Key market players in the Europe NGS market include Illumina, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., BGI Group, PerkinElmer Inc., Agilent Technologies, Inc., Qiagen, Eurofins Scientific, and Macrogen, Inc. These companies are at the forefront of driving innovation, research, and product development in the field of Next Generation Sequencing within the European market.

Europe's Next Generation Sequencing (NGS) market is currently witnessing significant growth due to advancements in technology, increased focus on precision medicine, and rising demand for personalized healthcare solutions. Market players such as Illumina, Thermo Fisher Scientific Inc., and Oxford Nanopore Technologies are leading the way with cutting-edge products and services that cater to the diverse needs of academic institutes, research centers, hospitals, pharmaceutical companies, and other end users across the region.

One key trend shaping the European NGS market is the growing adoption of NGS technology in diagnostic applications. With the ability to provide fast and accurate results, NGS is increasingly being used for genetic testing, oncology diagnostics, infectious disease diagnosis, and other clinical applications. This trend is expected to drive market growth as healthcare providers seek to leverage NGS for early disease detection, personalized treatment planning, and monitoring of treatment efficacy.

Another important factor influencing the market is the rising demand for NGS in drug discovery and development. Pharmaceutical and biotechnology companies are increasingly utilizing NGS technology to accelerate the drug discovery process, identify novel drug targets, and optimize clinical trial design. NGS enables researchers to analyze complex biological data, uncover disease mechanisms, and develop targeted therapies, thus driving innovation and efficiency in the drug development pipeline.

Moreover, the increasing focus on biomarker discovery and precision medicine is fueling the demand for NGS in Europe. By enabling comprehensive genomic profiling, NGS allows healthcare providers to identify individual genetic variations, predict disease risk, and tailor treatment strategies to the unique genetic makeup of patients. This personalized approach to healthcare is revolutionizing clinical practice and driving the adoption of NGS in precision medicine initiatives across the region.

Furthermore, agriculture and animal research are emerging as key application areas for NGS in Europe. By enabling high-throughput genomic analysis, NGS is revolutionizing plant and animal breeding programs, crop improvement strategies, and livestock management practices. Researchers are leveraging NGS technology to enhance food security, ensure sustainable agriculture, and improve the productivity and resilience of agricultural systems in the face of climate change and environmental challenges.

In conclusion, the European NGS market is poised for continued growth and innovation driven by key market players, technological advancements, and diverse applications across various sectors. With a strong emphasis on healthcare, research, and sustainability, Europe is at the forefront of harnessing the power of NGS to address complex challenges and shape the future of genomics and personalized medicine.The European Next Generation Sequencing (NGS) market is a dynamic and rapidly evolving space driven by advancements in technology, increasing adoption of precision medicine, and a growing demand for personalized healthcare solutions. Key market players such as Illumina, Thermo Fisher Scientific Inc., and Oxford Nanopore Technologies are leading the market with innovative products and services tailored to meet the diverse needs of various end users including academic institutes, research centers, hospitals, and pharmaceutical companies. These companies play a pivotal role in driving research, development, and innovation within the European NGS market, shaping the industry landscape and setting the pace for future growth and expansion.

One of the notable trends influencing the European NGS market is the rising adoption of NGS technology in diagnostic applications. The ability of NGS to provide rapid and precise results has made it a valuable tool in genetic testing, oncology diagnostics, infectious disease diagnosis, and other clinical applications. This trend is expected to fuel market growth as healthcare providers increasingly rely on NGS for early disease detection, personalized treatment planning, and monitoring treatment outcomes, thus enhancing patient care and outcomes.

Another significant factor driving the European NGS market is the growing demand for NGS in drug discovery and development. Pharmaceutical and biotechnology companies are leveraging NGS technology to expedite the drug discovery process, identify new drug targets, and optimize clinical trial designs. By enabling in-depth analysis of complex biological data, NGS helps researchers uncover disease mechanisms, develop targeted therapies, and enhance the efficiency of the drug development pipeline, ultimately leading to advancements in healthcare and pharmaceutical innovation.

Furthermore, the emphasis on biomarker discovery and precision medicine is propelling the demand for NGS in Europe. NGS enables comprehensive genomic profiling, allowing healthcare providers to identify individual genetic variations, predict disease susceptibility, and customize treatment approaches based on patients' unique genetic profiles. This personalized approach to healthcare is driving the adoption of NGS in precision medicine initiatives across the region, reshaping clinical practices and improving patient outcomes through tailored and precise medical interventions.

Additionally, agriculture and animal research are emerging as significant application areas for NGS in Europe. By enabling high-throughput genomic analysis, NGS is revolutionizing plant breeding programs, crop improvement strategies, and livestock management practices. Researchers are leveraging NGS technology to enhance food security, promote sustainable agriculture, and boost the productivity and resilience of agricultural systems in response to changing environmental conditions and global challenges.

In conclusion, the European NGS market presents robust growth opportunities driven by key market players, technological advancements, and diverse applications across various sectors. With a focus on healthcare innovation, research advancement, and sustainable practices, Europe is at the forefront of harnessing the potential of NGS to address complex challenges and shape the future of genomics, personalized medicine, and agriculture in the region.

Learn about the company’s position within the industry
https://www.databridgemarketresearch.com/reports/europe-next-generation-sequencing-ngs-market/companies

Frequently Asked Questions About This Report

How does Diversity & Inclusion (D&I) affect Europe Next Generation Sequencing (NGS) Market innovation?
How is Value-Based Pricing changing the Europe Next Generation Sequencing (NGS) Market industry?
What is the Psychology of Pricing in the Europe Next Generation Sequencing (NGS) Market industry?
How are Educational institutions adopting Europe Next Generation Sequencing (NGS) Market technologies?
How is the Europe Next Generation Sequencing (NGS) Market expected to change by 2033?
Who are the major raw material suppliers in the Europe Next Generation Sequencing (NGS) Market?
Which South American countries offer the best opportunities for Europe Next Generation Sequencing (NGS) Market expansion?
What are the upcoming trends in the Europe Next Generation Sequencing (NGS) Market for digital supply chains?
How is Energy Efficiency in manufacturing driving Europe Next Generation Sequencing (NGS) Market share?
How much is the Europe Next Generation Sequencing (NGS) Market expected to grow in absolute dollar terms by 2033?
What are the key players doing to target the Value segment of consumers?

Browse More Reports:

Asia-Pacific Digital Lending Platform Market
Saudi Arabia and GCC Modular Construction Market
Africa Digital Lending Platform Market
Global Osteoporosis Drug Market
Global Low Vision Aids Market
Global Precision Agriculture Market
Global Industrial Services Market
Global Polystyrene Market
Global Anti-Drone Market
Global Biomarkers Market
Global Cold Chain Market
Global Digital Lending Platform Market
Global Edutainment Market
Global Expanded Polystyrene Market
Global Liquefied Natural Gas (LNG) Carrier Market

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 993
Email:- corporatesales@databridgemarketresearch.com"